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Background: Toxoplasma gondii is a ubiquitous protozoan parasite that can infect humans and animals. The
severity of toxoplasmosis varies according to the immune status of the individual, parasite strain, and host species.
In mammalian species, it has been observed that severe lesions of acute toxoplasmosis form in visceral organs such
as the liver, lung, and spleen. Some epidemiological studies have reported an association of T. gondii infection with
liver cirrhosis.
Methods: Acute infection was induced in fifteen 30-day-old normal Swiss albino mice. The mice were infected by
intraperitoneal inoculation of 5000 T. gondii RH strain tachyzoites. The mice were sacrificed in groups of 5 at 2, 4,
and 6 days after inoculation. Another group of 5 mice were used as the controls. Anti-glial fibrillary acidic protein
(GFAP) and anti-T. gondii antibodies were used to compare GFAP-immunoreactive cells and anti-T. gondii–
immunopositive areas in the liver between the T. gondii-infected groups and the healthy controls, respectively.
Results: There was a significant correlation between the numbers of GFAP-positive hepatic stellate cells (HSCs)
when they were compared with T. gondii antigen immunostaining (p < 0.05). The amount of T. gondii
immunostaining increased significantly with the increase in the number of HSCs.
Conclusions: There is a significant relationship between the number of HSCs and T. gondii antigens, which may
represent an active role of HSCs in liver pathology and the pathobiology of T. gondii-related hepatitis.
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Toxoplasmosis is a parasitic disease caused by the proto-
zoan Toxoplasma gondii. It can infect humans and ani-
mals [1,2]. Typically, infection occurs after ingestion of
raw or undercooked meat containing tissue cysts or
through accidental environmental contamination by oo-
cysts. Only a small percentage of humans and animals
display clinical symptoms following infection. The sever-
ity of toxoplasmosis varies according to the immune sta-
tus of the individual, parasite strain, and host species
[2-5]. Severe lesions due to acute toxoplasmosis have
been observed in visceral organs such as the liver, lung,
and spleen of mammalian species [6]. It is known that
the parasite locates to the host liver, lymph nodes, eyes,
heart, and central nervous system, causing the lesions.
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reproduction in any medium, provided the orto hepatomegaly, granuloma, hepatitis, and necrosis.
Some epidemiological studies have reported an associ-
ation of T. gondii infection with liver cirrhosis [7]. An
important functional role of stellate cells in liver repair
as indicated by the close proximity of this cell type to
collagen fibers in injured livers [8]. Hepatic stellate cells
are known to play an important role in the development
of fibrosis and its advancement to cirrhosis. Activated
hepatic stellate cells differentiate from vitamin-A-storing
cells to contractile myofibroblastic cells responsible for
extracellular matrix (ECM) production in the damaged
liver. There is rising evidence mainly from the experi-
mental studies that HSCs acquire signaling pathways
required for stem/progenitor cell functions [9]. Hepatic
stellate cells can also interact with the sinusoidal space,
where other antigen presenting cells (APC) such as
dentritic cells and liver macrophages or kupffer cells
are existent. Therefore, HSC might also affect the Ag-
presenting function of these APC [10].l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cells. The non-parenchymal cells include endothelial cells,
Kupffer cells, liver-associated natural killer cells, hepatic
stellate cells (HSCs), and cholangiocytes [11].
HSCs are defined as mesenchymal cells. These cells
contain cytoskeletal proteins such as vimentin, α-smooth
muscle actin (α-SMA), desmin, and glial fibrillary acidic
protein (GFAP) [12,13]. In this study, we used GFAP to
identify HSCs.
To our knowledge, the role of HSCs in acute hepatic
lesions caused by T. gondii infection has not been inves-
tigated before. In this study, we demonstrated the role of




Twenty 30-day-old normal Swiss albino mice, weighing
approximately 25–30 g, were used to study acute T.
gondii infections. They were supplied by, The Turkish
Public Health Institution. The virulent T. gondii RH
strain, which is maintained in the Parasitology Labora-
tory of the Turkish Public Health Institution by continu-
ous passage every 3–4 days in mice, was used to induce
acute infection. Fifteen mice were infected by intraperi-
toneal inoculation of 5000 T. gondii RH tachyzoites. In
groups of 5, the mice were sacrificed at 2, 4, and 6
days after inoculation (DAI). Another healthy 5 mice
sacrificed at the beginning of study, were used as the
control in the immunohistochemical tests. The Animal
Care Committee of the University of Kırıkkale approved
this study. (permission date:11.02.2011, no. 11).
Necropsy and histopathology
Mice were sacrificed by cervical dislocation after they
had been anesthetized with pentobarbital. The livers
were removed and fixed in 10% formaldehyde in 0.1 M
phosphate buffer. The fixed tissue was dehydrated and
embedded in paraffin. The livers were sectioned to
5-μm thickness and stained with hematoxylin and
eosin (H&E).
Immunohistochemistry
HSCs were stained for immunohistochemistry (IHC) using
1:50 rabbit polyclonal anti-GFAP antibody (Thermo Fisher
Scientific Inc., USA). Toxoplasma antigens were demon-
strated as described previously [14] using 1:100 rabbit anti-
T. gondii antibody. All immunohistochemical tests were
performed according to a commercial streptavidin–biotin
kit (Thermo Fisher Scientific Inc.) protocol that used
diaminobenzidine (DAB) as a chromogen and Mayer’s
hematoxylin as a counterstain. Mouse brain experimentally
infected with the T. gondii Me49 strain served as a positive
internal control for the GFAP and T. gondii antigens. Thenegative control underwent the same process, but in the
absence of the primary antibody during the staining pro-
cedure. Sections on poly-L-lysine–coated slides were
deparaffinized. Endogenous peroxidase blocking was car-
ried out using 3% hydrogen peroxide in methyl alcohol for
10 min. Heat retrieval was carried out using Tris buffer so-
lution (TBS, pH 6.0) in a pressure cooker. The protein
blocking stage spanned 7 min. Treatment with the primary
antibody (anti-GFAP or anti-T. gondii) on the positive con-
trol slides was carried out for 1 h, followed by secondary
antibody for 30 min, and finally with streptavidin for
30 min. Slides were rinsed with TBS (2 × 5 min) after each
step. Sections were treated with DAB for 10 min and
counterstained with Mayer’s hematoxylin. Microphoto-
graphs were captured using an Olympus BX51 microscope
with a DP25 camera attachment (Japan).
Histomorphometric analysis and statistics
Leica QWin Plus image processing and analysis software
(Leica, Germany) was used to evaluate the intracellular
and interstitial immunostaining. Briefly, at least 5
randomly selected and consecutive × 20 objective micro-
scope fields were photographed. After calculation of the
proportional (% pixels) staining area to whole fields, the
mean % pixels staining area for each slide was calculated.
To evaluate non-parametric data, the Mann–Whitney
U-test was used to compare GFAP-immunoreactive cells
and anti-T. gondii–immunopositive areas in the liver
between the T. gondii-infected groups and the healthy
controls. The relationship between the HSCs and T.
gondii antigens were assessed using the Kruskal–Wallis




The control H&E-stained liver sections exhibited normal
hepatic architecture. In T.gondii infected mice, there
were multiple foci of hepatocellular necrosis and mono-
nuclear cell infiltrations (Figure 1). Mild lymphocytic
and plasma cell infiltrations were found in the periportal
areas and around the central veins. A few tachyzoite
clusters were present in the cytoplasm of the hepato-
cytes. Some hepatocytes were filled with a large group of
parasites (Figure 2). Karyorrhexis and karyolysis were
observed in the nuclei of necrotic hepatocytes (Figure 3).
Several small inflammatory lesions were present on
the surface of the liver, increasing in number and
progressing into deeper areas over time after inoculation
(Figure 3). While it was difficult to identify individual
parasites in tissue sections at 2 DAI, the parasites were
easily identified after immunohistochemical staining. At
4 and 6 DAI, parasite clusters became apparent in both
hepatocytes (H&E) and stellate cells (GFAP, IHC). Small
Figure 1 Foci of hepatocellular necrosis (asterisk) and
mononuclear cell infiltration (arrow). Hematoxylin and eosin
staining. Bar: 50 micrometer.
Figure 3 Karyorrhexis and karyolysis in the nuclei of necrotic
hepatocytes (arrowheads). There were several small inflammatory
lesions on the surface of the liver (arrow); the number of lesions
increased and progressed into deeper areas (asterisk). Hematoxylin
and eosin staining. Bar: 50 micrometer.
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ive tissue on the surface of the liver during the early
stages of infection at 2 DAI. There was a massive in-
crease in the numbers of parasites associated with the
connective tissue at 4 and 6 DAI as compared to that
at 2 DAI. The parasites were also present along the
connective tissue strands within the liver. The initial
inflammatory lesions contained few parasites, but these
increased rapidly over time, becoming numerous at 4
DAI. In addition, a number of hepatocytes and sinus-
oidal cells were infected, and a number of these
contained large groups of parasites.
T. gondii IHC
The statistical evaluation of T. gondii antigen expression
in the liver of T. gondii–infected and control animals is
listed in Table 1. T. gondii antigens were detected in all
infection groups. At 2 DAI, positive immunoreactions
were observed at the surface and underside of Glisson’sFigure 2 Hepatocytes filled with large groups of parasites
(arrows). Hematoxylin and eosin staining. Bar: 20 micrometer.capsule. At 4 and 6 DAI, necrotic foci, hepatocytes, and
HSCs containing tachyzoites were T. gondii antigen–
immunopositive (Figures 4 and 5). T. gondii antigen
immunoreactivity was not detected in specific locations.
Immunopositive reactions were observed throughout the
lobules.
HSCs detected by GFAP IHC
The statistical evaluation of GFAP antigen expression in
the HSCs of T. gondii-infected and control animals are
listed in Table 1. The number of HSCs was highest
(3.609) in the 6 DAI group as compared to 3.090, 2.515,
and 0.902 in the 4 DAI, 2 DAI, and control groups, re-
spectively (p < 0.05). There was a significant correlation
between the numbers of GFAP-positive HSCs when they
were compared with T. gondii antigen immunostaining
(p < 0.05). The amount of T. gondii immunostaining
increased significantly along with the increase in the
number of HSCs (Table 1).
The anti-GFAP antibody produced thin, irregular
immunopositive bands that lined the hepatic sinusoids of
the control animals (Figure 6). GFAP-positive HSCs were
present within the perisinusoidal space of Disse in the
liver, which is lined by parenchymal cells and fenestrated
sinusoidal endothelial cells (SECs). We observed a signifi-
cantly higher number of GFAP-positive HSCs at 2, 4, and
6 DAI, with activated stellate cells in the periportal,
intermediate, and periacinar areas (Figure 7). The GFAP-
positive HSCs also contained numerous proliferating
parasites (Figure 8).
Discussion
To our knowledge, this is the first experimental study of
acute T. gondii infection analyzing HSC activation and
its correlation with T. gondii-associated lesions in the
Table 1 GFAP and T. gondii immunohistochemical test results and statistical data
Antibody Control (n = 5) 2 DAI (n = 5) 4 DAI (n = 5) 6 DAI (n = 5) Statistical significance p*
Mean Std. deviation Mean Std. deviation Mean Std. deviation Mean Std. deviation p**
GFAP 0.902 0.080 2.515 0.383 3.090 0.171 3.609 0.316 <0.05
T. gondii 0 0 3.538 0.440 4.136 0.218 4.632 0.337 <0.05
DAI days after infection, GFAP Glial fibrillary acidic protein, T. gondii Toxoplasma gondii.
*Mann–Whitney test.
**Kruskal-Wallis test.
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the number of activated HSCs as detected by GFAP
staining. The number of activated HSCs was significantly
higher in the T. gondii infection groups than that in the
healthy group.
Acute liver injury was followed by an almost exclusive
increase in the number of HSCs, while HSCs as well as
liver myofibroblasts were involved in scar formation in
chronically injured livers [15].
Intravital microscopy imaging studies have determined
that apicomplexan parasites such as T. gondii invade the
liver, gradually move toward the surface of sinusoidal
epithelial cells to the Kupffer cells, finally entering and
developing in the cytoplasm of hepatocytes [16].
GFAP expression decreases upon HSC activation,
whereas desmin and α-SMA levels increase due to
HSC transformation into myofibroblast-like cells [17].
In this study, increased GFAP immunopositive HSCs were
related to the Toxoplasma gondii infection in the mice.
Additionally, the increased GFAP immunopositivity in the
lesions and perisinusoidal region suggests the accumulation
of HSCs at locations of active initial fibrogenesis.
The nature of stellate cells, traditionally considered
cells of mesenchymal origin due to their morphologic
features and their expression of molecules such as
vimentin, desmin, and α-SMA, has been questionedFigure 4 Anti-Toxoplasma gondii antigen immunopositivity
throughout the liver, in necrotic foci, and individual
hepatocytes. Diaminobenzidine chromogen and hematoxylin
counterstain. Bar: 50 micrometer.recently, as numerous studies have clearly demon-
strated the expression of neural and neuroendocrine
markers such as GFAP, nestin, neurotrophin receptor,
and synaptophysin [18].
In the normal liver, HSCs comprise approximately
1.4% of the total liver volume and are present at a ratio
of approximately 3.6–6 cells per 100 hepatocytes (1:20).
HSCs are typically located in the perisinusoidal space of
Disse, a recess between SECs and hepatocytes [18]. We
demonstrated activated HSCs using a specific polyclonal
antibody to detect GFAP. GFAP is an early marker of
stellate cell activation in the liver [19] and has been sug-
gested as a more reliable marker for perisinusoidal
stellate cells than desmin [20]. Buniatian et al. showed
both GFAP and vimentin were strongly expressed in the
perinuclear region and the cell processes of cultured
stellate cells. They also demonstrated staining for GFAP
highly overlapped with that for vimentin or desmin in
cultured stellate cells and with that for vimentin in the
liver sections. Desmin-positive cells were always also
GFAP-positive [20].
However, of the GFAP-positive cells only an estimated
50% were found desmin-positive. In addition, GFAP has
been established as one of several markers for identifying
HSCs [21].
Ueberham et al. were the first to demonstrate the
proliferation of midzonal and pericentral HSC popula-
tions [22]. They demonstrated the proliferative state ofFigure 5 Anti-Toxoplasma gondii antigen immunopositivity in
individual hepatocytes. Diaminobenzidine chromogen and
hematoxylin counterstain. Bar: 20 micrometer.
Figure 6 The anti-glial fibrillary acidic protein antibody
produced thin, irregular immunopositive bands, which lined
the hepatic sinusoids of the control animals. Diaminobenzidine
chromogen and hematoxylin counterstain. Bar: 50 micrometer.
Figure 8 Anti-glial fibrillary acidic protein–positive hepatic
stellate cells and sinusoids containing parasites (arrowheads),
parasite-containing hepatocytes (arrows). Diaminobenzidine
chromogen and hematoxylin counterstain. Bar: 20 micrometer.
Atmaca et al. Parasites & Vectors 2013, 6:135 Page 5 of 6
http://www.parasitesandvectors.com/content/6/1/135distinct sinusoidal cell populations by double-labeling ex-
periments, merging bromodeoxyuridine staining with
GFAP in the liver sections of choline-deficient, ethionine-
treated mice. The increase of HSCs in Toxoplasma hepatitis
can be described easily. The number of HSCs detected
increased at 2 DAI, and continued to increase at 4 and 6
DAI. These data are analogous to the T. gondii antigen.
This means that as the amount of T. gondii antigen in-
creased, the number of HSCs and histopathological lesions
in the liver increased in tandem.
An increasingly complex interplay between various cell
types in the liver and stellate cells has become apparent.
Hepatocytes, Kupffer cells, platelets, epithelial cells,
SECs, and neutrophils are known to interact with stellate
cells. Each of these cell types will release a subset ofFigure 7 Anti- glial fibrillary acidic protein (GFAP)–positive
hepatic stellate cells containing parasites (arrowheads);
parasite-containing hepatocytes (arrows) did not react with the
anti-GFAP antibody. Diaminobenzidine chromogen and
hematoxylin counterstain. Bar: 50 micrometer.mediators that have diverse effects on HSCs [18]. We
are curious as to whether HSCs also release mediators.
Future studies may help to determine or describe the
interaction of cytokine or mediator-releasing HSCs in
liver disease, including T. gondii infection. Moreover,
double immunohistochemical staining, that can be de-
fined as the detection of two or more targets on one
slide, thus increasing the information obtained from
each tissue section, can be performed on HSCs.
It is widely accepted that HSCs contribute to liver fi-
brosis. HSCs reside within the perisinusoidal space of
Disse in the liver lined by parenchymal cells and fenes-
trated SECs. HSCs can develop into myofibroblast-like
cells that synthesize extracellular matrix proteins and
contribute to liver fibrosis [8,23-25].
Another experimental study has yielded similar infor-
mation, determining that HSCs are directly involved in
the restoration of liver mass even in vivo [26]. Rastogi
et al. [9] reported a possible dynamic role of HSCs in
liver regeneration and the pathobiology of acute-on
-chronic liver failure. Our study also highlights the prob-
ability that HSCs play an important role in liver regener-
ation. This is because the proliferation of parasites in
HSCs and the number of HSCs increase in parallel. This
may indicate the beginning of liver regeneration with
HSCs. We do not know how HSCs can play a role in
treated liver injury from this study. After successful
treatment of T. gondii infection in liver, we would like to
see the regeneration and the status of hepatic stellate
cells.
Future studies in liver diseases of different etiologies
and stages using immunohistochemical markers and
molecular studies of HSCs are needed to confirm these
initial observations, and might provide further insight
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improve therapeutic interventions in liver diseases asso-
ciated with T. gondii.
Conclusions
Thus, the number of activated HSCs in hepatitis due to
T. gondii was found to be higher than healthy liver.
There is a significant relationship between the number
of HSCs and T. gondii antigens, which may represent an
active role of HSCs in liver pathology and the pathobiol-
ogy of T. gondii-related hepatitis. In addition, the find-
ings from this study would be useful for investigations of
experimentally induced liver lesions in mice.
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